Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Clinical Trial to Evaluate the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer

NCT03721120 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT03721120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03721120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Clinical Trial to Evaluate the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
Lead sponsor
Centre Leon Berard
Phase
Not applicable
Overall status
Completed
Start date
April 10, 2019
Completion date
July 1, 2023
Enrollment
319 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic lung cancer